Repression of the Wnt-TCF crypt/adenoma signature in patient samples and in xenografts versus in vitro cultures indicated the possibility that Wnt-TCF signaling might be replaced by other signaling pathways during tumor progression, ending in further reprogramming (with immortalization potentially emerging in cells within the same population through a secondary oncogenic pathway). Here, HNF4A is linked to adenoma.